Herpes simplex virus vectors for gene therapy in Parkinson's disease and other diseases of the nervous system.
作者信息
Latchman D S
机构信息
Department of Molecular Pathology, Windeyer Institute of Medical Sciences, University College London, UK.
出版信息
J R Soc Med. 1999 Nov;92(11):566-70. doi: 10.1177/014107689909201107.
Abstract
摘要
相似文献
1
Herpes simplex virus vectors for gene therapy in Parkinson's disease and other diseases of the nervous system.
J R Soc Med. 1999 Nov;92(11):566-70. doi: 10.1177/014107689909201107.
2
Herpes virus vectors for gene therapy in the nervous system.
Biochem Soc Trans. 1999 Dec;27(6):847-51. doi: 10.1042/bst0270847.
3
Herpes simplex virus vectors for Parkinson's disease.
Int Rev Neurobiol. 2003;55:223-41. doi: 10.1016/s0074-7742(03)01010-9.
4
Viral vectors in the treatment of Parkinson's disease.
Mov Disord. 2000 Jan;15(1):9-17. doi: 10.1002/1531-8257(200001)15:1<9::aid-mds1004>3.0.co;2-5.
5
Problems in the use of herpes simplex virus as a vector.
Int Rev Neurobiol. 2003;55:99-109. doi: 10.1016/s0074-7742(03)01003-1.
6
Potential use of herpes simplex virus (HSV) vectors for gene therapy of neurological disorders.
Brain. 1997 Jul;120 ( Pt 7):1245-59. doi: 10.1093/brain/120.7.1245.
7
Herpes simplex virus-based vectors.
Int J Exp Pathol. 2004 Oct;85(4):177-90. doi: 10.1111/j.0959-9673.2004.00383.x.
8
Herpes vector-mediated gene transfer in treatment of diseases of the nervous system.
Annu Rev Microbiol. 2004;58:253-71. doi: 10.1146/annurev.micro.58.030603.123709.
9
Gene therapy with herpes simplex virus vectors: progress and prospects for clinical neuroscience.
Neuroscientist. 2001 Dec;7(6):528-37. doi: 10.1177/107385840100700609.
10
Use of HSV vectors to modify the nervous system.
Curr Opin Drug Discov Devel. 2002 Mar;5(2):289-95.
引用本文的文献
1
Gene therapy for brain tumors.
Curr Oncol Rep. 2000 Sep;2(5):463-72. doi: 10.1007/s11912-000-0067-z.
本文引用的文献
1
High efficiency gene transfer to the central nervous system of rodents and primates using herpes virus vectors lacking functional ICP27 and ICP34.5.
Gene Ther. 1998 Aug;5(8):1137-47. doi: 10.1038/sj.gt.3300700.
2
Protection of neuronal cells from apoptosis by Hsp27 delivered with a herpes simplex virus-based vector.
J Biol Chem. 1999 Feb 19;274(8):5061-9. doi: 10.1074/jbc.274.8.5061.
3
Heat shock proteins: protective effect and potential therapeutic use (review).
Int J Mol Med. 1998 Oct;2(4):375-81. doi: 10.3892/ijmm.2.4.375.
4
Bcl-2 transcription from the proximal P2 promoter is activated in neuronal cells by the Brn-3a POU family transcription factor.
J Biol Chem. 1998 Jul 3;273(27):16715-22. doi: 10.1074/jbc.273.27.16715.
5
Human gene therapy.
Nature. 1998 Apr 30;392(6679 Suppl):25-30. doi: 10.1038/32058.
6
Intracerebral recombinant HSV-1 vector does not reactivate latent HSV-1.
Gene Ther. 1997 Dec;4(12):1300-4. doi: 10.1038/sj.gt.3300535.
7
Gene therapy of murine motor neuron disease using adenoviral vectors for neurotrophic factors.
Nat Med. 1997 Apr;3(4):429-36. doi: 10.1038/nm0497-429.
8
Therapeutic potentials for glial cell line-derived neurotrophic factor (GDNF) based upon pharmacological activities in the CNS.
Rev Neurosci. 1996 Jul-Sep;7(3):165-76. doi: 10.1515/revneuro.1996.7.3.165.
9
Biology of glial cell line-derived neurotrophic factor (GDNF): implications for the use of GDNF to treat Parkinson's disease.
Neurodegeneration. 1996 Sep;5(3):197-205. doi: 10.1006/neur.1996.0027.
10
Gene delivery to the central and peripheral nervous systems of mice using HSV1 ICP34.5 deletion mutant vectors.
Gene Ther. 1996 Oct;3(10):886-91.
Zotero 插件